Skip to content

DR. SOFIE KERKAERT

Active
Private limited companyfounded 2021active for 5 yearsVuurkruisenlaan(Kok) 15, 8670 Koksijde, BelgiumKBO/BCE: BE 0774.993.376
Summary

DR. SOFIE KERKAERT has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €312,993 and a net result of €80,676. Equity is growing by about 36% per year across the filed financial years. Its solvency ranks better than 75% of 20,612 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Register details

Identification
Legal formPrivate limited company
Founded04-10-2021
Financial year end31-12
Activities, NACEBEL 2025
86210General medical practice
E-invoicing
Reachable via Peppol
Peppol ID 0208:0774993376
Also 9925:BE0774993376

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 25 October 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.

Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.

Sites & property

Location & real-estate footprint
Registered office, Koksijde · 2 establishment units since 2021
registered office establishment All 2 establishment units on the map
Ground area
2,035 m²
Building footprint
339 m²
Building volume
1,975 m³
2 parcels, Flanders · tallest building 10.4 m. Linked by address, not a title deed.
2 establishment units
DR. SOFIE KERKAERT
Vuurkruisenlaan(Kok) 15, 8670 KoksijdeGeneral medical practice
since 2021unit no. 2.322.605.216
DR. SOFIE KERKAERT
Arsenaalstraat 32, 8620 NieuwpoortGeneral medical practice
since 2021unit no. 2.323.007.171
2 parcels
Flanders 2 (100%)
Cadastral parcel Region Area Buildings Height / floors
38016B0803/00Y007 Flanders 1,042 m² 1 · 192 m² 10.4 m · 2
38014D0548/00D000 Flanders 993 m² 1 · 147 m² 7.4 m · 2
How the parcels are linked
Good to know
Both parcels match the address exactly.